Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

NCT03525210 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

271

Enrollment

OTHER

Sponsor class

Conditions

Human Papilloma Virus
Hiv
Organ Transplants

Interventions

BIOLOGICAL: 9-valent HPV vaccine

Sponsor

Universitaire Ziekenhuizen KU Leuven